Free Trial

Bowhead Specialty (BOW) Expected to Announce Earnings on Tuesday

Bowhead Specialty logo with Finance background

Bowhead Specialty (NYSE:BOW - Get Free Report) is expected to be issuing its Q1 2025 quarterly earnings data before the market opens on Tuesday, May 6th. Analysts expect the company to announce earnings of $0.34 per share and revenue of $105.17 million for the quarter.

Bowhead Specialty (NYSE:BOW - Get Free Report) last issued its earnings results on Tuesday, February 25th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.07. The business had revenue of $184.77 million for the quarter, compared to the consensus estimate of $102.12 million. On average, analysts expect Bowhead Specialty to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Bowhead Specialty Trading Up 3.3 %

BOW stock traded up $1.31 during midday trading on Friday, hitting $41.31. The company's stock had a trading volume of 255,644 shares, compared to its average volume of 214,557. Bowhead Specialty has a 12 month low of $22.14 and a 12 month high of $42.29. The company has a 50 day moving average of $38.08 and a two-hundred day moving average of $34.92.

Insider Activity at Bowhead Specialty

In other news, Director Ava Schnidman bought 1,493 shares of Bowhead Specialty stock in a transaction dated Friday, February 28th. The shares were acquired at an average price of $33.41 per share, with a total value of $49,881.13. Following the completion of the purchase, the director now owns 1,893 shares in the company, valued at $63,245.13. The trade was a 373.25 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Analyst Ratings Changes

A number of analysts have issued reports on the stock. Keefe, Bruyette & Woods reduced their price target on shares of Bowhead Specialty from $44.00 to $43.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. JMP Securities boosted their target price on Bowhead Specialty from $38.00 to $40.00 and gave the stock a "market outperform" rating in a research report on Friday, April 11th. Piper Sandler began coverage on Bowhead Specialty in a research note on Wednesday, April 16th. They issued an "overweight" rating and a $44.00 price objective on the stock. Finally, JPMorgan Chase & Co. increased their target price on Bowhead Specialty from $30.00 to $35.00 and gave the company a "neutral" rating in a research report on Tuesday, April 8th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, Bowhead Specialty presently has a consensus rating of "Moderate Buy" and an average price target of $37.17.

Read Our Latest Research Report on Bowhead Specialty

Bowhead Specialty Company Profile

(Get Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Recommended Stories

Should You Invest $1,000 in Bowhead Specialty Right Now?

Before you consider Bowhead Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.

While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress Is POURING Into This Stock
The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines